UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022504
Receipt number R000025925
Scientific Title A cohort study of prevalence and natural history of upper gastrointestinal disease in the Japanese population --- a multi-center study ---
Date of disclosure of the study information 2016/06/02
Last modified on 2023/06/02 19:08:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A cohort study of prevalence and natural history of upper gastrointestinal disease in the Japanese population --- a multi-center study ---

Acronym

UGID cohort study

Scientific Title

A cohort study of prevalence and natural history of upper gastrointestinal disease in the Japanese population --- a multi-center study ---

Scientific Title:Acronym

UGID cohort study

Region

Japan


Condition

Condition

upper gastrointestinal disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to clarify the changes of clinical parameters associated with GERD and Functional Dyspepsia during 5 years follow-up period in the subjects who undergo health checkup

Basic objectives2

Others

Basic objectives -Others

to clarify the prevalence of GERD and FD, and to clarify the natural history of GERD and FD.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1. prevalence of GERD and FD at the registration.
2. prevalence of GERD and FD at the end of the observation period.
3. incidence, exacerbation rates, and remission rates of GERD and FD in the observation period.

Key secondary outcomes

1. factors associated with prevalence of GERD and FD at the registration.
2. factors associated with natural history of GERD and FD.
3. incidence of esophageal cancer and gastric cancer in the observation period.
4. association between eradication of Helicobacter pylori and incidence of upper gastrointestinal tract diseases


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. subjects who undergo health checkup including upper gastrointestinal endoscopy
2. more than 20 years old

Key exclusion criteria

subjects who are judged as unsuitable for this study by the investigators

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Yuzo
Middle name
Last name Kodama

Organization

Kobe University Graduate School of Medicine

Division name

Department of Gastroenterology

Zip code

650-0017

Address

Kusunoki-cho 7-1-5 Cuo-ku, Kobe 650-0017, Japan

TEL

078-382-6305

Email

gcare@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Tsuyoshi
Middle name
Last name Fujita

Organization

Yodogawa Christian Hospital

Division name

Health Care and Promotion Center

Zip code

533-0024

Address

1-7-50 Kunijima, Higashiyodogawa-ku, Osaka 533-0024, Japan

TEL

06(6322)2250

Homepage URL

http://www.med.kobe-u.ac.jp/gicare/

Email

gcare@med.kobe-u.ac.jp


Sponsor or person

Institute

UGID Study Group

Institute

Department

Personal name



Funding Source

Organization

National University Corporation, Kobe University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Gastro-Intestinal Medicare Research and Education Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital

Address

Kusunoki-cho 7-1-5 Cuo-ku, Kobe 650-0017, Japan

Tel

0783826609

Email

kansatsu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都第二赤十字病院(京都府)、加古川中央市民病院(兵庫県)、北播磨総合医療センター(兵庫県)、福井赤十字病院(福井県)、大阪府済生会中津病院(大阪府)、ホテルオークラ神戸クリニック(兵庫県)、淀川キリスト教病院(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 02 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

8888

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2012 Year 11 Month 22 Day

Date of IRB

2013 Year 04 Month 05 Day

Anticipated trial start date

2013 Year 05 Month 20 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 06 Month 30 Day

Date analysis concluded

2026 Year 03 Month 31 Day


Other

Other related information

The baseline data were collected from a prospective, multicenter, cohort study in which Japanese subjects who underwent the upper endoscopy for health screening. 8883 subjects were enrolled. and prevalence and risk factors associated with erosive GERD (EE), non-erosive GERD (NERD) and functional dyspepsia (FD) were analyzed.
1. Erosive GERD (EE) was observed in 1418 subjects (16.1%), and severe symptomatic EE, mild symptomatic EE, and asymptomatic EE were 16.7%, 36.9%, and 67.4%, respectively. Symptomatic EE was more frequently overlapped with FD, and were associated with strong stress, anxiety, atrophic gastritis and use of PPI, compared with mild and asymptomatic EE.
2. NERD was observed in 504 subjects (5.7%). NERD subjects more took anti-acid secretory agents, and were associated with the factors related to the psychologic stress. One third of NERD subjects were overlapped with FD. NERD-FD overlapped subjects were common in female, and had more severe reflux symptoms.
3. FD was observed in 399 subjects (4.5%), and the half of FD subjects were overlapped with NERD. Compared with asymptomatic subjects without organic lesions, the FD-NERD plus the FD-alone subjects were more often took gastroprotective agents, and were associated with the psychologic stress, kyophosis, low BMI and less ARB.


Management information

Registered date

2016 Year 05 Month 27 Day

Last modified on

2023 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025925